@article{ref1,
title="Hemodialysis following butoxyethanol ingestion",
journal="Journal of toxicology - clinical toxicology",
year="1998",
author="Burkhart, K. K. and Donovan, J. W.",
volume="36",
number="7",
pages="723-725",
abstract="CASE REPORT: This case report describes a 19-year-old male who ingested a product containing butoxyethanol, propylene glycol, and monoethanolamine. Neurotoxicity, acidosis, and butoxyacetic acid persisted after hemodialysis. Hemodialysis was used to treat the acidosis, but the half-life of butoxyacetic acid did not appear to have been significantly altered. Fomepizole, a recently approved alcohol dehydrogenase inhibitor for ethylene glycol intoxication, was not available at the time of this case. Residual neurological deficits persisted after recovery from this severe intoxication by a glycol ether.<p /><p>Language: en</p>",
language="en",
issn="0731-3810",
doi="",
url="http://dx.doi.org/"
}